Lipocine Inc. (LPCN)
NASDAQ: LPCN · Real-Time Price · USD
1.680
-0.010 (-0.59%)
At close: Oct 15, 2026, 4:00 PM EDT
1.640
-0.040 (-2.38%)
After-hours: Oct 15, 2026, 7:48 PM EDT
Lipocine Market Cap
Lipocine has a market cap or net worth of $13.85 million as of October 15, 2026. It is the 39,546th most valuable company in the world and the 5,433rd biggest in the United States. Its market cap has decreased by 20.40% in one year.
Market Cap
13.85M
Enterprise Value
-9.16M
1-Year Change
-20.40%
Global Rank
Country Rank
#5,433 United States
Category
ChartMarket Cap Chart
Since March 21, 2014, Lipocine's market cap has decreased from $82.30M to $13.85M, a decrease of -83.17%. That is a compound annual growth rate of -13.21%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 15, 2026 | 13.90M | -68.83% |
| Dec 31, 2025 | 44.60M | 70.88% |
| Dec 31, 2024 | 26.10M | 76.35% |
| Dec 29, 2023 | 14.80M | -57.95% |
| Dec 30, 2022 | 35.20M | -59.77% |
| Dec 31, 2021 | 87.50M | -2.02% |
| Dec 31, 2020 | 89.30M | 811.22% |
| Dec 31, 2019 | 9.80M | -64.87% |
| Dec 31, 2018 | 27.90M | -61.73% |
| Dec 29, 2017 | 72.90M | 8.48% |
| Dec 30, 2016 | 67.20M | -71.53% |
| Dec 31, 2015 | 236.00M | 250.67% |
| Dec 31, 2014 | 67.30M | -18.23% |
| Mar 21, 2014 | 82.30M | - |
View and export this data all the way back to 2014. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Pasithea Therapeutics | 14.86M |
| Daré Bioscience | 14.71M |
| Vyome Holdings | 13.97M |
| Cellectar Biosciences | 13.94M |
| Tvardi Therapeutics | 13.94M |
| Estrella Immunopharma | 13.92M |
| Allarity Therapeutics | 13.52M |
| Citius Pharmaceuticals | 13.45M |